Literature DB >> 22949020

Cross-lingual asynchronous telepsychiatry: disruptive innovation?

Peter M Yellowlees1, Alberto Odor, Michelle Burke Parish.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22949020     DOI： 10.1176/appi.ps.2012op945

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN： 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  5 in total

Review 1.  Review of Use of Asynchronous Technologies Incorporated in Mental Health Care.

Authors:  Steven Chan; Luming Li; John Torous; David Gratzer; Peter M Yellowlees
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 5.285

Review 2.  Telepsychiatry Today.

Authors:  Steven Chan; Michelle Parish; Peter Yellowlees
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

3.  Asynchronous Telepsychiatry: A Component of Stepped Integrated Care.

Authors:  Peter Yellowlees; Michelle Burke Parish; Álvaro González; Steven Chan; Don Hilty; Ana-Maria Iosif; Robert McCarron; Alberto Odor; Lorin Scher; Andrés Sciolla; Jay Shore; Glen Xiong
Journal:  Telemed J E Health       Date:  2017-10-12       Impact factor: 3.536

4.  Asynchronous Telepsychiatry Interviewer Training Recommendations: A Model for Interdisciplinary, Integrated Behavioral Health Care.

Authors:  Michelle Burke Parish; Alvaro Gonzalez; Donald Hilty; Steven Chan; Glen Xiong; Lorin Scher; David Liu; Andres Sciolla; Jay Shore; Robert McCarron; Debra Kahn; Ana-Maria Iosif; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2021-01-12       Impact factor: 5.033

5.  Primary Care Physician Adherence to Telepsychiatry Recommendations: Intermediate Outcomes from a Randomized Clinical Trial.

Authors:  Monica K Lieng; Magi S Aurora; Young Kang; Joseph M Kim; James P Marcin; Steven R Chan; Jamie L Mouzoon; Daniel J Tancredi; Michelle Parish; Alvaro D Gonzalez; Lorin Scher; Glen Xiong; Robert M McCarron; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2021-11-02       Impact factor: 5.033
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.